Yellow fever - World Health Organization (WHO)
May 31, 2023 · Yellow fever is an epidemic-prone mosquito-borne vaccine preventable disease that is transmitted to humans by the bites of infected mosquitoes. Yellow fever is caused by an arbovirus (a virus transmitted by vectors such mosquitoes, ticks or other arthropods) transmitted to humans by the bites of infected Aedes and Haemagogus mosquitoes.
Yellow fever
Aug 2, 2023 · Yellow fever vaccine is safe, affordable, and a single dose provides life-long protection against yellow fever disease. The yellow fever vaccine provides immunity within one week in 95% of people vaccinated. A booster dose is not needed. Yellow fever vaccination is carried out for the following reasons: to protect populations living in areas at ...
Yellow fever - World Health Organization (WHO)
Nov 8, 2023 · Yellow fever is an epidemic-prone vector-borne vaccine preventable viral disease that is transmitted to humans by the bites of infected mosquitos. In some of the unvaccinated individuals, the virus can cause severe illness including jaundice and bleeding (severe cases).
Countries with risk of yellow fever transmission and countries ...
Overview . The Country List is a compilation of key information to facilitate international travel. The information provided for each country includes vaccination requirements for international travellers as provided by States Parties to the International Health Regulations (2005) (IHR), as well as WHO recommendations for vaccination against yellow fever, poliomielytis, and malaria …
ICG for yellow fever - World Health Organization (WHO)
In 2000 a global shortage of yellow fever vaccine occurred, mainly due to a combination of the relatively long time needed to produce the vaccine, and poor epidemiological surveillance and reporting in at-risk countries which made forecasting vaccine needs difficult.
Lifetime validity of one dose of Yellow fever vaccine
May 24, 2014 · Lifetime validity of one dose of Yellow fever vaccine. Amendment to Annex 7 of IHR (2005) 24 May 2014
Yellow fever vaccine and HIV infection - World Health …
However, the vaccine is contraindicated for people who are severely immunocompromised. 6 The benefits of mass vaccination campaigns for yellow fever are recognized in endemic countries, and millions of individuals are vaccinated against the disease every year in countries where the prevalence of HIV is 1–5% among those aged 15–49 years. In ...
Yellow Fever - World Health Organization (WHO)
Yellow fever (YF) is a mosquito-borne, viral haemorrhagic fever that is endemic in tropical regions of Africa and South America. "Aedes Aegypti" is the vector of YF virus in the urban human-to-human cycle of the transmission, whereas in the jungle (forest, sylvatic) monkey-to-monkey - and accidentally monkey-to-human - cycle, several different ...
Yellow Fever: Vaccine Preventable Diseases Surveillance Standards
Apr 30, 2020 · The purpose of this document is to provide World Health Organization (WHO)-recommended standards for conducting surveillance for vaccine preventable diseases (VPDs). VPD surveillance provides vital information to help countries understand disease burden and epidemiology to inform vaccine policy and strategy. This document is intended to provide a set …
Yellow fever – Suriname - World Health Organization (WHO)
Mar 28, 2017 · Travellers with contraindications for yellow fever vaccine (children below nine months, pregnant or breastfeeding women, people with severe hypersensitivity to egg antigens, and severe immunodeficiency) or over 60 years of age should consult their health professional for advice based on risk benefit analysis;